Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBL
2051
DELISTED
CBL& Associates Properties, Inc.
CBL
| $3.38M | ﹤0.01% |
3,247,600
+1,574,800
| +94% | +$1.82M |
|
|
BREW
2052
DELISTED
Craft Brew Alliance, Inc.
BREW
| $3.37M | ﹤0.01% |
240,848
-35,300
| -13% | -$504K |
|
|
ECOM
2053
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $3.37M | ﹤0.01% |
384,200
+74,100
| +24% | +$769K |
|
2054
Seres Therapeutics
MCRB
$46.3M
| $3.36M | ﹤0.01% |
52,170
+7,060
| +16% | +$670K |
|
2055
Artivion
AORT
$1.34B
| $3.35M | ﹤0.01% |
111,790
-78,610
| -41% | -$2.33M |
|
2056
Diamondrock Hospitality Co
DRH
$2.64B
| $3.34M | ﹤0.01% |
+323,358
| New | +$3.41M |
|
2057
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $3.34M | ﹤0.01% |
115,100
+72,900
| +173% | +$2.05M |
|
2058
Kingstone Companies
KINS
$293M
| $3.34M | ﹤0.01% |
385,900
+100,100
| +35% | +$1.07M |
|
2059
Flexsteel Industries
FLXS
$301M
| $3.33M | ﹤0.01% |
195,493
+21,700
| +12% | +$445K |
|
|
GLUU
2060
DELISTED
Glu Mobile Inc.
GLUU
| $3.33M | ﹤0.01% |
463,400
-1,093,800
| -70% | -$10.1M |
|
|
SAND
2061
DELISTED
Sandstorm Gold
SAND
| $3.33M | ﹤0.01% |
600,240
+463,440
| +339% | +$2.49M |
|
2062
Vicor
VICR
$9.42B
| $3.33M | ﹤0.01% |
+107,100
| New | +$3.44M |
|
|
CASA
2063
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $3.33M | ﹤0.01% |
517,100
+6,800
| +1% | +$49.7K |
|
|
PFBI
2064
DELISTED
Premier Financial Bancorp
PFBI
| $3.33M | ﹤0.01% |
221,688
+6,100
| +3% | +$98.1K |
|
|
YELL
2065
DELISTED
Yellow Corporation Common Stock
YELL
| $3.33M | ﹤0.01% |
824,986
+240,433
| +41% | +$1.39M |
|
2066
ACNB Corp
ACNB
$649M
| $3.32M | ﹤0.01% |
84,000
-1,100
| -1% | -$41.2K |
|
2067
FS Bancorp
FSBW
$318M
| $3.32M | ﹤0.01% |
127,898
-10,742
| -8% | -$269K |
|
2068
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.4B
| $3.31M | ﹤0.01% |
30,800
-35,300
| -53% | -$3.74M |
|
|
OSG
2069
DELISTED
Overseas Shipholding Group Inc.
OSG
| $3.3M | ﹤0.01% |
1,756,034
-63,668
| -3% | -$118K |
|
|
EXPR
2070
DELISTED
Express, Inc.
EXPR
| $3.3M | ﹤0.01% |
60,448
-10,847
| -15% | -$741K |
|
|
ELVT
2071
DELISTED
Elevate Credit, Inc.
ELVT
| $3.29M | ﹤0.01% |
799,847
+188,747
| +31% | +$842K |
|
|
CMCM
2072
Cheetah Mobile
CMCM
$88.5M
| $3.29M | ﹤0.01% |
185,456
+88,036
| +90% | +$2.31M |
|
|
AGRX
2073
DELISTED
Agile Therapeutics
AGRX
| $3.29M | ﹤0.01% |
1,127
+60
| +6% | +$168K |
|
2074
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $3.29M | ﹤0.01% |
40,300
+9,500
| +31% | +$742K |
|
2075
SmartFinancial
SMBK
$900M
| $3.26M | ﹤0.01% |
150,184
+20,084
| +15% | +$415K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.